ImmuCell (ICCC) announced that it is initiating Investigational Product use of Re-Tain. The company intends to use this opportunity to test market acceptance of the product through a controlled launch. This initiative also helps the company utilize available inventory before shelf-life expiration. This opportunity is not expected to generate significant revenue or profit.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC: